Skip to content
M

M. Pramod Kumar

Publications (3)

Educational Intervention to Improve the Knowledge, Attitude, Practices of Health Care Professionals and Students Regarding the Pharmacovigilance in Tertiary Care Hospitals

M. Pramod Kumar, T. Sasi Kumar, C. Indira, K. Gayatri, B. Hima Bindhu & A. Arjun Kumar · International Journal of TROPICAL DISEASE & Health · 2021

Introduction: An adverse drug reaction (ADR) is any noxious, unintended, and undesired effect of a drug, which occurs at the doses which are used in humans for prophylaxis, diagnosis, or therapy, which is reported by β€˜β€˜the science and activities relating to the detection, assessm...

Open access Research Article 10.9734/ijtdh/2021/v42i1830535

Prescribing Pattern in Geriatrics with Cardio Vascular Diseases using Beers Criteria

E. Pavan Kumar, V. Sreedhar, P. Ramakrishna Reddy, L. Reddenna, M. Pramod Kumar, B. Jayanthi, N. Sirisha & K. Salma · Journal of Pharmaceutical Research International · 2021

Aim: Cardiovascular disease (CVD) is a major health problem throughout the world and a common cause of premature morbidity and mortality. CVD is a general category of diseases that affects the heart and the circulatory system. The main aim of the study is to assess the prescribin...

Open access Research Article 10.9734/jpri/2021/v33i531176

Clinical Efficacy and Safety Profile of Lurasidone Comparing with Risperidone: Randomized, Open Label, Clinical Study

V. Sreedhar, L. Reddenna, T. Rajavardhana, J. Thippe Rudra, E. Pavan Kumar, M. Pramod Kumar, M. Kalyan Sai, T. Sivasaileela, Y. Yamini, B. Sreelekha, B. Nishkala & M. Mahesh · Journal of Pharmaceutical Research International · 2021

There are diverse studies which afford evidences that risperidone is as effective as second generation antipsychotics in treating positive symptoms and more effective in treatment of negative symptoms. This study is intended to find the clinical efficacy and safety profile of lur...

Open access Research Article 10.9734/jpri/2021/v33i431167